Nephros, Inc. (OTC:NEPH)
Industry: Healthcare

OFF LIST - 1690 consecutive market days: OFF LIST as of 09/18/2009 Through 11/14/2016

Nephros, Inc., a commercial stage medical device and commercial product company, develops and sells liquid purification filters and hemodiafiltration (HDF) systems primarily in the United States. The company's ultrafilters are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from water borne pathogens, such as legionella and pseudomonas, as well as in military and outdoor recreation, commercial, and other healthcare facilities. It offers HDF systems for use in conjunction with a hemodialysis machine that enables nephrologists to provide HDF treatment to patients with end stage renal disease; and hemodiafilters for use as dialyzers in an hemodialysis treatment, as well as other disposables for use in the hemodiafiltration treatment process. The company was founded in 1997 and is headquartered in South Orange, New Jersey.

Current Quote*
Last: $0.591
Change: -0.009
Book: $8.929
Volume: 1,855

As Of: 10/19 15:57 ET
*Quotes delayed by 20min.

BuyIns.Net Alerts for Symbol NEPH

  • No BuyIns.Net Alerts Available for NEPH

Graphs for NEPH

3 Month Graph

6 Month Graph

1 Year Graph